Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Media

Mallinckrodt Pharmaceuticals Receives 2018 Science Leadership Award

  • by Gena Holthaus
  • Posted on May 15, 2018May 15, 2018
  • Achievements

Mallinckrodt Pharmaceuticals was recently named the 2018 Science Leadership Award recipient by the Academy of Science in St. Louis, Missouri. The award is presented annually to distinguished individuals or organizations who have made important contributions […]

Read More

Make It In America Listening Tour Stops at Mallinckrodt’s Regenerative Medicine Site in Madison, Wisconsin

  • by Gena Holthaus
  • Posted on April 23, 2018May 11, 2018
  • Media

House Minority Whip Steny Hoyer (D-MD) and Congressman Mark Pocan (D-WI) recently received a hands-on tour of Mallinckrodt’s Madison, Wis. regenerative medicine site, where they learned about the company’s innovative work happening there. The Mallinckrodt […]

Read More

Mallinckrodt Earns Somerset County Planning Board Land Development Honor

  • by Gena Holthaus
  • Posted on February 21, 2018April 23, 2018
  • Achievements

Mallinckrodt’s Specialty Brands office site in Bedminster, N.J. earned recognition as a 2017 Somerset County Planning Board Land Development Award honoree in the Commercial category. A program of the Somerset County Planning Board, the 35th […]

Read More

Mallinckrodt’s Cathi Ponciroli Earns Missouri Lawyers Media’s inaugural In-House Counsel Award

  • by Gena Holthaus
  • Posted on December 8, 2017
  • Achievements

Cathi Ponciroli, Associate General Counsel for Mallinckrodt’s Business Development & Licensing (BD&L) Legal team, is one of 22 in-house attorneys across the state of Missouri who recently received Missouri Lawyers Media’s inaugural In-House Counsel Award. […]

Read More

Posts navigation

Older posts
Newer posts
  • NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

    September 30, 2020
  • Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

    August 19, 2020
  • MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

    June 30, 2020
  • An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

    June 3, 2020
  • Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

    May 29, 2020

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.